Publicacións nas que colabora con Luis Madero López (12)

2020

  1. First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors

    Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042

2016

  1. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells

    Cancer Letters, Vol. 371, Núm. 2, pp. 161-170

2013

  1. A role for the CXCR3/CXCL10 axis in rasmussen encephalitis

    Pediatric Neurology, Vol. 49, Núm. 6, pp. 451-457.e1

2010

  1. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: An exploratory study

    Cancer Gene Therapy, Vol. 17, Núm. 7, pp. 476-483

2007

  1. Early-phase adaptations to intrahospital training in strength and functional mobility of children with leukemia

    Journal of Strength and Conditioning Research, Vol. 21, Núm. 1, pp. 173-177

  2. Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow

    Journal of Pediatric Hematology/Oncology, Vol. 29, Núm. 6, pp. 388-392

2006

  1. Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury

    British Journal of Sports Medicine, Vol. 40, Núm. 8, pp. 719-722

  2. Physical activity during treatment in children with leukemia: A pilot study

    Applied Physiology, Nutrition and Metabolism, Vol. 31, Núm. 4, pp. 407-413

  3. Terapias celulares en oncología

    Oncologia

  4. Veinte años de experiencia en el tratamiento de la leucemia linfoblástica aguda

    Anales de Pediatria, Vol. 65, Núm. 3, pp. 198-204

2005

  1. Intrahospital supervised exercise training: A complementary tool in the therapeutic armamentrium against childhood leukemia

    Leukemia

  2. Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors

    Cancer Gene Therapy, Vol. 12, Núm. 4, pp. 341-349